Patient Marketing
Reach the patients who need your treatment. Before they find someone else.
Most effective treatments are invisible to the patients who would benefit most. We build compliant, direct-to-patient systems that create awareness, build trust, and drive enquiries across markets and at measurable cost.
The problem
665,000 UK private patients in 2023. Most never heard of your treatment.
The UK private sector cared for a record 665,000 patients in 2023. Self-pay is now 32% higher than pre-COVID. Patients are actively researching their own treatment options but they can only choose from what they can find.
If your treatment isn’t visible at the moment a patient is searching, it doesn’t matter how effective it is. A clinician’s recommendation helps but patients make their own decisions before they ever reach a clinic.
Patient marketing is the system that puts your treatment in front of the right people, at the right moment, with messages that are compliant, credible, and compelling enough to generate an enquiry.
How it works
Three steps. One system. Measurable at every stage.
01
Capture attention
Reach a 58-year-old with knee pain searching 'alternative to knee replacement' at 11pm on a Tuesday. Paid social, paid search, landing page. Cost per enquiry measured in the morning. Built around the specific patient profiles most likely to convert for your treatment, by geography, life stage, and condition severity.
02
Build trust
Convert awareness into confidence. Patient films, clinical explainers, real-world evidence, and compliant messaging that gives patients the information they need to take the next step and the confidence to believe the treatment is right for them.
03
Promote action
Drive measurable enquiries into your clinic or sales team. Optimised landing pages, enquiry forms, and follow-up workflows designed to move a patient from awareness to a booked consultation tracked and reported in real time.
What we deliver
Everything a patient acquisition system needs.
Direct-to-patient campaigns
Paid social and paid search campaigns targeting specific patient profiles built for compliance across UK, EU, and international markets. Creative, media buying, and ongoing optimisation included.
Patient film production
Real patient stories, produced in compliance with medical device and pharma regulations. The most effective single creative asset for patient acquisition we've seen CTRs of 8.83% for a patient film that a healthcare benchmark puts at under 1.5%.
In-clinic patient materials
Brochures, waiting room materials, and digital assets that support the clinical conversation. Designed to educate patients, reduce appointment time, and increase treatment confidence at the point of care.
Co-marketing with clinicians
We work with your clinical network to co-produce patient-facing content that carries genuine clinical authority. Surgeons and clinicians are among the most trusted voices in patient decision-making we help you leverage that credibly.
International patient acquisition
Running the same system across multiple markets simultaneously. We've operated across UK, Germany, Sweden, and beyond with per-market tracking, localised compliance, and the infrastructure to add new markets without rebuilding from scratch.
Patient persona development
Before any creative is made, we map your patient population: life stage, condition severity, motivation profile, and digital behaviour. Every campaign decision follows from this channel, message, creative format, and budget allocation.
Results live campaigns
What patient marketing looks like when it’s working.
Numbers from live campaigns across medical devices and private-pay treatments. Not averages actual results.
Contura · Arthrosamid
A live direct-to-patient acquisition system running simultaneously across UK, Germany, and Sweden for a novel polyacrylamide hydrogel knee treatment.
285
Patient enquiry forms total
£29
Blended cost per acquisition
12.8x
Blended return on ad spend
4.75%
Average Meta CTR vs. sub-1.5% benchmark
Global orthopaedics · Knee OA device
Direct-to-patient marketing built from scratch for a non-surgical knee treatment for a condition most GPs didn't know was treatable.
128
Patient referrals in a single month
157%
Uplift in conversions vs prior period
Top 10%
Google Ads performance nationally
AGENCY & University of Bath
Painful Conversations. Research that changes how you communicate with patients.
Produced with Professor Christopher Eccleston at the Centre for Pain Research, University of Bath. Five free eBooks on why improved communication is the key to overcoming the paradox of pain and what healthcare companies can do about it.
Download the series free15.5m
people in England living with chronic pain
20%
of the world's population
28m
in the UK in everyday pain
1in4
UK adults with chronic pain
Common questions
What clients ask before the first call.
Is direct-to-patient marketing allowed in healthcare?
Yes with the right compliance framework. Regulations vary by country and product type, but compliant patient marketing is well-established across medical devices and private-pay healthcare. We build compliance review into every campaign before launch, and our claims matrix approach means nothing goes out that hasn't been checked against the relevant regulatory environment.
How long does it take to see results?
The Arthrosamid campaign generated enquiries within the first month of going live. Typically we see initial data within 2-4 weeks, with optimised results by month 2-3. The system improves over time as we learn what creative and targeting works best for your specific patient profile.
Does this work for private-pay and NHS-funded treatments?
Both. Private-pay campaigns focus on self-selecting patients motivated enough to fund their own treatment. NHS-adjacent campaigns focus on awareness and directing patients to discuss treatment options with their GP or specialist. The channel mix and messaging differ; the methodology is the same.
Can you run campaigns in markets outside the UK?
Yes. We've run concurrent campaigns across UK, Germany, and Sweden simultaneously. Each market requires localised compliance review and messaging adaptation we handle both. Adding a new market uses the same infrastructure, so the marginal cost of expansion is significantly lower than the original build.
Do you work directly with clinics or only with manufacturers?
Both. We work with medical device manufacturers running national patient campaigns, and with individual clinic groups or hospital groups who want to drive patient enquiries for specific services. Co-marketing between manufacturer and clinic is a particularly effective approach the treatment maker and the clinic both benefit.
Ready to start
Get patients to your clinic this quarter.
A Triage Call is 30 minutes. We’ll look at your treatment, your target patient profile, and your markets and tell you what a patient acquisition system would look like for you specifically.